Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post

Panacea Biotec Ltd Financial Statements & Historical Data

Updated
Report details
Last Updated:
Author: |Social: XLinkedIn
COMPANY FINANCIAL DATA

Reported figures at a glance

Stored figures, not live quotes. Price record: 5 October 2026, 9:29 pm +05:30. Financial reporting periods are shown in the tables below.

Stored share price350₹ per share
Reported P/ENot availableTimes
Book value per share136₹ per share
Reported ROCE2.43 %%
Data sources and reporting basis

Sources: Company data source. Check the company filings linked by the source for the reporting basis and exceptional items.

Different tables can have different reporting dates and accounting bases. Verify the company filings before comparing figures. Missing data is not treated as zero.

How Getaka handles sources, dates and corrections. Page revision dates describe the page, not the age of every financial figure.

Stored market and accounting figures

Price record: 5 October 2026, 9:29 pm +05:30. Not a live quote.

MeasureStored figure
Market Cap2,152 Cr.
Current Price350
High / Low648/292
Stock P/ENot available
Book Value136
Dividend Yield0.00 %
ROCE2.43 %
ROE2.42 %
Face Value1.00

Market cap is in ₹ crore; prices and per-share values are in ₹. P/E is a multiple; yield, ROCE and ROE are percentages. Book value is an accounting figure, not an estimate of the share's investment value.

Competitors

Stock Name ⇩Market Cap ⇩Current Price ⇩High / Low ⇩Stock P/E ⇩Book Value ⇩Dividend Yield ⇩ROCE ⇩ROE ⇩Face Value ⇩
Panacea Biotec Ltd 2,152 Cr. 350 648/292 1360.00 %2.43 %2.42 % 1.00
Syncom Formulations (India) Ltd 2,174 Cr. 23.1 27.5/10.225.6 4.390.43 %24.8 %17.6 % 1.00
Beta Drugs Ltd 2,219 Cr. 2,001 2,808/99048.7 2410.00 %19.2 %18.8 % 10.0
Fredun Pharmaceuticals Ltd 2,258 Cr. 1,363 1,600/45450.8 1700.02 %21.5 %15.8 % 10.0
Indoco Remedies Ltd 2,278 Cr. 247 317/162 1020.08 %0.96 %9.36 % 2.00
Industry Average17,447.00 Cr1,244.2854.37211.240.39%26.16%16.59%6.06

All Competitor Stocks of Panacea Biotec Ltd

FINANCIALS

Quarterly performance

Compare sales, expenses, operating profit and net profit on one chart, across the same reporting quarters.

Sales, expenses & profits

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Quarterly Chart Table

MetricJun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales 129.19143.02150.50136.46115.72147.35163.49132.53166.70141.13165.19166.75199.57
Expenses 139.50146.58150.65142.50129.71140.35155.53159.41167.88158.92153.45164.18193.90
Operating Profit -10.31-3.56-0.15-6.04-13.997.007.96-26.88-1.18-17.7911.742.575.67
OPM % -7.98%-2.49%-0.10%-4.43%-12.09%4.75%4.87%-20.28%-0.71%-12.61%7.11%1.54%2.84%
Other Income 33.826.008.4613.556.547.426.3936.3016.999.105.055.266.98
Interest 1.000.910.850.820.870.980.991.040.862.141.851.201.18
Depreciation 9.489.319.118.818.738.688.988.428.398.348.457.887.90
Profit before tax 13.03-7.78-1.65-2.12-17.054.764.38-0.046.56-19.176.49-1.253.57
Tax % 15.73%6.56%33.33%-6.13%-6.86%1.05%-1.37%4,875.00%39.63%-26.92%40.06%-20.00%38.38%
Net Profit 10.98-8.29-2.20-1.99-15.884.714.44-1.993.96-14.013.89-1.002.20
EPS in Rs 1.79-1.35-0.37-0.32-2.580.780.74-0.310.66-2.270.650.080.38

Last Updated: September 29, 2026, 6:31 pm

FINANCIALS

Annual performance

Compare sales, expenses, operating profit and net profit across financial years. Trailing figures remain in the table.

Sales, expenses & profits

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Earnings per share

₹ per share

Hover or tap the chart for dated values.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Profit & Loss Chart Table

Last Updated: October 1, 2026, 9:07 pm

MetricMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales 510687653544593457544625661460559559640673
Expenses 582643541505509591484548674558579584644670
Operating Profit -72441123984-1346077-13-98-20-25-52
OPM % -14%6%17%7%14%-29%11%12%-2.0%-21%-3.5%-4.4%-0.7%0.3%
Other Income 1832870628338-2191,68715462553626
Interest 15010512710110110517418518144466
Depreciation 7167736857544346443937353333
Profit before tax -111-99-19-67-6645-178-1461,449131-8-7-10
Tax % 2%3%10%-16%15%17%9%1%26%363%201%10%-3%
Net Profit -113-108-21-56-7638-194-1481,078-34-2-9-7-9
EPS in Rs -18.29-17.38-2.98-8.89-12.076.15-31.69-24.09175.91-5.42-0.19-1.37-0.88-1.16
Dividend Payout % 0%0%0%0%0%0%0%0%0%0%0%0%0%

YoY Net Profit Growth

Year2014-20152015-20162016-20172017-20182018-20192019-20202020-20212021-20222022-20232023-20242024-20252025-2026
YoY Net Profit Growth (%)4.42%80.56%-166.67%-35.71%150.00%-610.53%23.71%828.38%-103.15%94.12%-350.00%22.22%
Change in YoY Net Profit Growth (%)0.00%76.13%-247.22%130.95%185.71%-760.53%634.24%804.67%-931.53%197.27%-444.12%372.22%

Panacea Biotec Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 12 years from 2014-2015 to 2025-2026.

Growth

Compounded Sales Growth
10 Years:-2%
5 Years:1%
3 Years:-5%
TTM:12%
Compounded Profit Growth
10 Years:5%
5 Years:12%
3 Years:21%
TTM:29%
Stock Price CAGR
10 Years:13%
5 Years:19%
3 Years:43%
1 Year:71%
Return on Equity
10 Years:Not available
5 Years:Not available
3 Years:-6%
Last Year:-5%

Last Updated: September 5, 2025, 12:05 pm

FINANCIALS

Balance sheet

Compare reserves and borrowings across the same financial years. Reserves are an accounting balance, not available cash.

Reserves & borrowings

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Balance Sheet Data Table

Last Updated: September 26, 2026, 9:01 pm

MonthMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital 666666666666
Reserves 449426350303344193-235871837836829829
Borrowings 1,1111,1059949416467428203420212224
Other Liabilities 364317440349379449587848407378433404
Total Liabilities 1,9301,8541,7891,5981,3761,3901,1781,7591,2711,2411,2901,262
Fixed Assets 1,1441,0711,001949806657609622600582567576
CWIP 15516130402324341742102128144
Investments 1597756051340310
Other Assets 6166147506025427035341,114615517592532
Total Assets 1,9301,8541,7891,5981,3761,3901,1781,7591,2711,2411,2901,262
FINANCIALS

Cash generation

Compare operating cash and free cash flow across reported periods. Negative values remain visible.

Operating & free cash flow

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Cash Flows

MonthMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity + 3791131118105-30107-108-422-0-2717
Cash from Investing Activity + -3716-2655-6-35-481,2834301065-40
Cash from Financing Activity + -1-117-107-164-10191-47-1,176-18-3-3-1
Net Cash Flow -1-10-29-22612-2-10735-25
Free Cash Flow 3085107103100-2189-119-424-71-77-37
CFO/OP 96%64%320%146%-77%-36%141%-2,235%429%-12%108%-511%
Free cash flowAll reported figures · use a chart icon for peer comparison

Free Cash Flow Table

Free cash flow reported in the stored cash-flow statement (₹ Cr)
PeriodMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Free Cash Flow30.0085.00107.00103.00100.00-21.0089.00-119.00-424.00-71.00-77.00-37.00

This table and the chart use the Free Cash Flow row from the same stored cash-flow statement. Free cash flow generally measures operating cash flow after capital expenditure; check the source definition and reporting basis. It is not operating profit minus borrowings.

Financial efficiency feed. Source: www.screener.in. The source URL identifies consolidated accounts. Values from separate feeds can differ, even for the same period; they are not interchangeable. Use each table’s period labels. Data methodology.

FINANCIALS

Financial & business efficiency

Compare collection, inventory, payment and working-capital cycles together in days. Returns on capital and equity follow in a separate percentage chart.

Working capital

Days

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Returns on capital & equity

%

Hover or tap the chart for dated values.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Financial Efficiency Data Table

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days 685279958471464945483747
Inventory Days 375404516770651173344311296292282391
Days Payable 430272318607540572463440327256244413
Cash Conversion Cycle 13184278259195-328-73-8014837625
Working Capital Days -343-12627-46-96-36395-43-229-5-246
ROCE %-8%0%4%2%3%-16%4%5%-6%-10%-4%-5%
FINANCIALS

Ownership trends

Compare ownership groups across the same reporting dates. Shareholder counts appear separately below.

Shareholding comparison

%

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Shareholder count

Shareholders

Hover or tap the chart for dated values.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Shareholding Pattern

MonthSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters 73.59%73.59%73.59%73.47%72.87%72.49%72.48%72.48%72.48%72.48%72.48%72.48%
FIIs 0.26%0.26%0.27%0.26%0.37%0.38%1.16%0.79%1.06%1.36%1.60%2.31%
DIIs 0.57%0.69%0.84%1.07%1.16%1.16%1.49%1.52%1.80%1.85%1.96%2.25%
Public 25.58%25.46%25.30%25.21%25.60%25.96%24.86%25.20%24.65%24.31%23.96%22.96%
No. of Shareholders 48,87847,09146,24245,51339,98235,44633,59334,25633,59334,59732,62033,532
Mutual fund holdingsReported fund ownership · Expand table

Mutual Fund Holdings Data Table

Fund NameNo of SharesAUM (%)Amount Invested (Cr)Previous Number of SharesPrevious DatePercentage Change
Motilal Oswal S&P BSE Healthcare ETF 117 0.02 01172025-04-22 17:25:230%

Alternate ratio feed. Source: www.way2wealth.com. The accounting basis and ratio definitions require verification against the source. Values from separate feeds can differ, even for the same period; they are not interchangeable. Use each table’s period labels. Data methodology.

FINANCIALS

Ratios from the alternate data feed

Related measures share a chart and a common unit. Use the dated figures below to examine any change.

Profitability ratios

%

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Liquidity ratios

Multiple (×)

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Interest coverage

Multiple (×)

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Valuation multiples

Multiple (×)

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Key Financial Ratios

MonthMar 25Mar 24Mar 23Mar 22Mar 21
FaceValue 1.001.001.001.001.00
Basic EPS (Rs.) -1.37-0.19-5.43175.98-24.11
Diluted EPS (Rs.) -1.37-0.19-5.43175.98-24.11
Cash EPS (Rs.) 4.265.750.87183.11-16.68
Book Value[Excl.RevalReserv]/Share (Rs.) 132.76133.94133.63138.09-41.36
Book Value[Incl.RevalReserv]/Share (Rs.) 132.76133.94133.63138.09-41.36
Revenue From Operations / Share (Rs.) 91.2891.2975.09107.96102.01
PBDIT / Share (Rs.) -0.850.93-7.56-0.4714.14
PBIT / Share (Rs.) -6.54-5.06-13.95-7.606.70
PBT / Share (Rs.) -1.300.242.09236.54-23.56
Net Profit / Share (Rs.) -1.42-0.24-5.51175.98-24.12
NP After MI And SOA / Share (Rs.) -1.37-0.19-5.43175.98-24.11
PBDIT Margin (%) -0.931.02-10.06-0.4313.86
PBIT Margin (%) -7.16-5.53-18.57-7.046.56
PBT Margin (%) -1.420.262.78219.10-23.09
Net Profit Margin (%) -1.55-0.26-7.33163.01-23.64
NP After MI And SOA Margin (%) -1.49-0.20-7.22163.01-23.63
Return on Networth / Equity (%) -1.02-0.14-4.04126.990.00
Return on Capital Employeed (%) -4.34-3.32-9.09-4.755.44
Return On Assets (%) -0.64-0.09-2.6160.47-12.52
Long Term Debt / Equity (X) 0.010.010.010.03-2.92
Total Debt / Equity (X) 0.010.010.010.03-2.92
Asset Turnover Ratio (%) 0.440.440.300.240.31
Current Ratio (X) 1.491.571.711.301.20
Quick Ratio (X) 0.900.991.101.030.79
Inventory Turnover Ratio (X) 2.861.111.021.140.58
Interest Coverage Ratio (X) -1.361.60-10.43-0.010.46
Interest Coverage Ratio (Post Tax) (X) -10.54-9.48-29.74-2.310.21
Enterprise Value (Cr.) 2610.05620.65454.38355.931682.86
EV / Net Operating Revenue (X) 4.671.110.980.532.69
EV / EBITDA (X) -496.96108.22-9.81-122.8619.43
MarketCap / Net Operating Revenue (X) 4.831.331.441.371.74
Price / BV (X) 3.320.900.801.07-4.34
Price / Net Operating Revenue (X) 4.831.331.441.371.74
EarningsYield 0.000.00-0.051.19-0.13
Advertisements
Explore Industry-wise Company financial data